Patient Global Impression of Change in Patients with Alport Syndrome in the CARDINAL Phase 3 Trial

被引：0

作者：

Chertow, Glenn M. ^{[1
]}

Pergola, Pablo E. ^{[2
]}

Agarwal, Rajiv ^{[3
]}

Andreoli, Sharon P. ^{[4
]}

Appel, Gerald B. ^{[5
]}

Bangalore, Sripal ^{[6
]}

Block, Geoffrey A. ^{[7
]}

Chin, Melanie ^{[8
]}

Gibson, Keisha L. ^{[9
]}

Goldsberry, Angie ^{[8
]}

Iijima, Kazumoto ^{[10
]}

Inker, Lesley A. ^{[11
]}

Kashtan, Clifford E. ^{[12
]}

Knebelmann, Bertrand ^{[13
]}

Mariani, Laura H. ^{[14
]}

Meyer, Colin J. ^{[8
]}

Nozu, Kandai ^{[10
]}

O'Grady, Megan ^{[8
]}

Silva, Arnold L. ^{[15
]}

Stenvinkel, Peter ^{[16
]}

Torra, Roser ^{[17
]}

Warady, Bradley A. ^{[18
]}

机构：

[1] Stanford Univ, Sch Med, Stanford, CA USA

[2] Renal Associates PA, San Antonio, TX USA

[3] Indiana Univ Sch Med, Indianapolis, IN USA

[4] Indiana Univ Hlth, Riley Hosp Children, Indianapolis, IN USA

[5] Columbia Univ, Irving Med Ctr, New York, NY USA

[6] NYU Langone Hlth, New York, NY USA

[7] US Renal Care, Plano, TX USA

[8] Reata Pharmaceut Inc, Irving, TX USA

[9] Univ N Carolina, Chapel Hill Sch Med, Chapel Hill, NC USA

[10] Kobe Daigaku Daigakuin Igakukei Kenkyuka Igakub, Kobe, Hyogo, Japan

[11] Tufts Med Ctr, Boston, MA USA

[12] Univ Minnesota Hlth, Minneapolis, MN USA

[13] Inst Necker Enfants Malades, Paris, France

[14] Univ Michigan, Sch Med, Ann Arbor, MI USA

[15] Boise Kidney & Hypertens Inst, Meridian, ID USA

[16] Karolinska Inst, Stockholm, Sweden

[17] Univ Autonoma Barcelona, Barcelona, Spain

[18] Childrens Mercy Hosp & Clin, Kansas City, MO USA

来源：

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2021年 / 32卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

PO1303

引用

页码：418 / 418

页数：1

共 50 条

[1] SAFETY OF BARDOXOLONE METHYL IN PEDIATRIC PATIENTS WITH ALPORT SYNDROME IN CARDINAL PHASE 3 TRIAL
Warady, Bradley
Chadha, Vimal
Chin, Melanie
Gbadagesin, Rasheed A.
Gibson, Keisha
Gipson, Debbie
Goldsberry, Angie
Lieberman, Kenneth
Meyer, Colin
Meyers, Kevin
Nozu, Kandai
O'Grady, Megan
Rheault, Michelle
Kashtan, Clifford
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
[2] BASELINE CHARACTERISTICS IN THE "CARDINAL" TRIAL: A PHASE 3 STUDY OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME
Knebelmann, Bertrand
Appel, Gerald
Block, Geoffrey
Chin, Melanie
Goldsberry, Angie
Inker, Lesley
Kashtan, Clifford
Meyer, Colin
Nozu, Kandai
Pergola, Pablo
Rastogi, Anjay
Rheault, Michelle
Silva, Arnold
Sprague, Stuart
Warady, Bradley
Gross, Oliver
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 104 - 104
[3] Study Design and Baseline Characteristics of the CARDINAL Trial: A Phase 3 Study of Bardoxolone Methyl in Patients with Alport Syndrome
Chertow, Glenn M.
Appel, Gerald B.
Andreoli, Sharon
Bangalore, Sripal
Block, Geoffrey A.
Chapman, Arlene B.
Chin, Melanie P.
Gibson, Keisha L.
Goldsberry, Angie
Iijima, Kazumoto
Inker, Lesley A.
Knebelmann, Bertrand
Mariani, Laura H.
Meyer, Colin J.
Nozu, Kandai
O'Grady, Megan
Silva, Arnold L.
Stenvinkel, Peter
Torra, Roser
Warady, Bradley A.
Pergola, Pablo E.
AMERICAN JOURNAL OF NEPHROLOGY, 2021, 52 (03) : 180 - 189
[4] Improvement in the Clinical Global Impression of Change with Voxelotor in Patients with Sickle Cell Disease in the Phase 3 HOPE Trial
Smith, Wally R.
Hankins, Jane S.
Abboud, Miguel R.
Cong, Ze
Sorof, Jonathan
Gray, Sarah
Hoppe, Carolyn
Telfer, Paul
BLOOD, 2020, 136
[5] THE CARDINAL TRIAL OF BARDOXOLONE METHYL IN ALPORT SYNDROME: WHEN MARKETING INTERESTS PREVAIL OVER PATIENTS CLINICAL NEEDS
Ruggenenti, Piero
NEPHRON, 2023, 147 (08) : 465 - 469
[6] LOREXYS PHASE 2A RESULTS: PATIENT'S GLOBAL IMPRESSION OF CHANGE (PGIC)
Pyke, R.
Clayton, A.
JOURNAL OF SEXUAL MEDICINE, 2019, 16 (06): : S30 - S30
[7] The Patient Global Impression of Change-a Powerful Complimentary Tool for Assessing Improvement in Concussion Patients
Hungerford, Lars
Remigio-Baker, Rosemay
Bailie, Jason
Ivins, Brian
Lopez, Juan
Ettenhofer, Mark
ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2024, 39 (07) : 967 - 967
[8] Agreement between improvements in patient global impression of change and other measures of improvement and attack resolution observed in a phase 2 trial with KVD900 in patients with hereditary angioedema
Audhya, Paul K.
Smith, Michael D.
Williams, Peter
Yea, Christopher M.
Cohn, Danny M.
ALLERGY AND ASTHMA PROCEEDINGS, 2022, 43 (06) : 563 - 563
[9] A PHASE 2/3 STUDY OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME
Gross, Oliver
Appel, Gerald
Block, Geoffrey
Chin, Melanie
Goldsberry, Angie
Inker, Lesley
Meyer, Colin
Pergola, Pablo
Simon, James
Warady, Bradley
Zaoui, Phillip
Rheault, Michelle
Kashtan, Clifford
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
[10] A PHASE 2/3 STUDY OF THE EFFICACY AND SAFETY OF BARDOXOLONE METHYL IN PATIENTS WITH ALPORT SYNDROME
Meyer, Colin
Warnock, David
Chin, Melanie
Goldsberry, Angie
McCullough, Peter
O'Grady, Megan
Toto, Robert
Ward, Keith
Block, Geoffrey
Pergola, Pablo
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 480 - 480

← 1 2 3 4 5 →